Grail, Inc. (GRAL) rose 13.90% to $86.02, gaining $10.50, after announcing a strategic collaboration with Samsung C&T and Samsung Electronics to bring its Galleri multi-cancer early detection or MCED test to Asia.
The stock opened at $77.48, reached a high of $88.60, and a low of $76.50, compared to the previous close of $75.52. It trades on the NasdaqGS with a volume of 3.8 million shares, significantly above its average daily volume.
The collaboration expands Grail's global reach and provides capital support for further commercialization. Shares are trading near the upper end of their 52-week range of $45.10-$89.25.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.